Hepatitis C treatment experiences and decision making among patients living with HIV infection.
about
Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factorsBarriers to hepatitis C antiviral therapy in HIV/HCV co-infected patients in the United States: a reviewPatient capacity and constraints in the experience of chronic disease: a qualitative systematic review and thematic synthesisEngaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France)"Every drug goes to treat its own disease…" - a qualitative study of perceptions and experiences of taking anti-retrovirals concomitantly with anti-malarials among those affected by HIV and malaria in Tanzania.Challenges facing providers caring for HIV/HCV-coinfected patientsEvaluation of pharmacokinetics, user handling, and tolerability of peginterferon alfa-2a (40 kDa) delivered via a disposable autoinjector device.Qualitative analysis of patient-centered decision attributes associated with initiating hepatitis C treatment.Epidemiological Distribution and Genotype Characterization of the Hepatitis C Virus Among HIV Patients in Kashan, Iran.'Makes you wanna do treatment': benefits of a hepatitis C specialist clinic to clients in Christchurch, New Zealand.Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: insights from the ETHOS study.Modafinil and armodafinil treatment for fatigue for HIV-positive patients with and without chronic hepatitis C.
P2860
Q26853671-9B25D32D-3887-4FA7-8CBE-A0C116FB893EQ27010548-E11AFE24-575A-4EAC-826E-9AE2364B8AC4Q27313543-BC083D3C-A35F-4C2C-9BE7-06CCA3327D7EQ34191840-0112D4C1-59B3-48B1-8D89-056CB7EFF6F6Q34996394-8A63E26E-7E3D-4EF2-BCA4-3C912771FEDFQ35068905-72BA2D39-B840-4232-AB17-B91F56DC7F99Q35604803-7D1DF070-EF2D-4D08-8F51-B6F7FDF6C796Q35796138-DF74DCA8-C09E-4C74-BC55-44A7CD40BC85Q37246458-836C624A-3632-4C26-999F-CCD628A8F257Q39510747-E648545D-5214-4663-919B-38C2D70552AEQ42251464-C5A77DD9-1C9A-44A4-A433-34694473DC8BQ46217129-F0CB4EFB-FE25-4D84-97BC-ABBBAF23C7AA
P2860
Hepatitis C treatment experiences and decision making among patients living with HIV infection.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Hepatitis C treatment experien ...... nts living with HIV infection.
@ast
Hepatitis C treatment experien ...... nts living with HIV infection.
@en
type
label
Hepatitis C treatment experien ...... nts living with HIV infection.
@ast
Hepatitis C treatment experien ...... nts living with HIV infection.
@en
prefLabel
Hepatitis C treatment experien ...... nts living with HIV infection.
@ast
Hepatitis C treatment experien ...... nts living with HIV infection.
@en
P2860
P1476
Hepatitis C treatment experien ...... ents living with HIV infection
@en
P2093
Lisa Fink Ogawa
Susan Sullivan-Bolyai
P2860
P356
10.1016/J.JANA.2009.07.009
P407
P50
P577
2009-10-22T00:00:00Z